Výsledky vyhledávání - "Yoav H Messinger"

Akademický článek

Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL

Autor: Alex Hoover, Dave Watson, Paige Reimche, Lynn Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M. Turcotte

Publikováno v: BMC Research Notes, Vol 17, Iss 1, Pp 1-4 (2024)

Abstract Objective Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy and among the most common malignancies in young adults and requires a unique pattern of healthcare utilization including an acute/emergent presentation and

Externí odkaz: https://doaj.org/article/96c9a53faabe47528ac86a6ace030474

Zobrazit plný text záznamu

Plný text ve formátu HTML

Real-World Cost of Pediatric Acute Lymphoblastic Leukemia Care Among Commercially Insured Individuals in the United States: Effect of Era and Age at Diagnosis

Autor: Lucie M. Turcotte, Dave Watson, Lynn Tanner, Alex Hoover, Laura Gilchrist, Mike Finch, Yoav H. Messinger

Publikováno v: JCO oncology practice. 18(11)

PURPOSE: Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Five-year survival is approaching 90%. In efforts to further improve outcomes, it is critical to consider the cost of ALL care. MATERIALS AND METHODS: Commercial ins

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f6cb99e49235181d8fa19a8ae53d95
https://pubmed.ncbi.nlm.nih.gov/36166724

Zobrazit plný text záznamu

Akademický článek

STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis

Autor: Nathalia Benavides, Waldo A. Spessott, Maria L. Sanmillan, Marcelo Vargas, Mylynda S. Livingston, Nissa Erickson, Tamara C. Pozos, Margaret E. McCormick, Emilia Scharrig, Yoav H. Messinger, Claudio G. Giraudo

Publikováno v: Frontiers in Immunology, Vol 11 (2020)

Neonatal hemophagocytic lymphohistiocytosis (HLH) is a medical emergency that can be associated with significant morbidity and mortality. Often these patients present with familial HLH (f-HLH), which is caused by gene mutations interfering with the c

Externí odkaz: https://doaj.org/article/18dbbd268bc545599c209ae63407fe44

Zobrazit plný text záznamu

Akademický článek

Successful reduction of high-sustained anti-idursulfase antibody titers by immune modulation therapy in a patient with severe mucopolysaccharidosis type II

Autor: Katherine H. Kim, Yoav H. Messinger, Barbara K. Burton

Publikováno v: Molecular Genetics and Metabolism Reports, Vol 2, Iss C, Pp 20-24 (2015)

We report on a 6 year old boy with severe MPS II undergoing immune modulation therapy due to high IgG antibody titers to IV idursulfase and no significant decline in urinary GAG levels since initiating enzyme replacement therapy. He has complete defi

Externí odkaz: https://doaj.org/article/7170e94c63cf4da2a9b0d8e64681e870

Zobrazit plný text záznamu

Autor: Alexander T. Nelson, Anna Dybvik, Paige Mallinger, Shelly Weiss McQuaid, Dave Watson, Laura A. Harney, Douglas R. Stewart, Louis P. Dehner, Yoav H. Messinger, Alicia S. Kunin‐Batson, Kris Ann P. Schultz

Publikováno v: Pediatr Blood Cancer

PURPOSE: Pleuropulmonary blastoma (PPB) is the most common lung cancer of infancy and early childhood and is associated with germline DICER1 variants. Type I and Ir PPB are cystic lesions treated surgically, with a subset of children with type I rece

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6aefe7cfa1746a42760afffffc1b3c9
https://doi.org/10.1002/pbc.30077

Zobrazit plný text záznamu

Effect of Prearrival Orders on Time to Antibiotics for Immunocompromised Oncology Patients Presenting to the Emergency Department With Fever

Autor: Patrick L, Carolan, Shea M, Lammers, Cynthia M, Anderson, Yoav H, Messinger

Publikováno v: Pediatric Emergency Care.

Pediatric cancer patients with fever are at risk for invasive bacterial infection. The administration of antibiotics to these patients within the first hour of evaluation is viewed as a quality of care metric with potential to improve outcome. We sou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca15a0c523663ff49c34b7fef789982
https://doi.org/10.1097/pec.0000000000002822

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání